Rare diseases
Investigational molecules
Locations
Study Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
CzechiaLong-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma
CzechiaStudy on Upadacitinib for Adults with Active Axial Spondyloarthritis
CzechiaStudy on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
CzechiaStudy of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes
CzechiaStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
CzechiaStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
CzechiaStudy of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy
CzechiaStudy on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis
CzechiaStudy on the Effects of Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Adults
CzechiaStudy on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis
CzechiaStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
